John S. Kovach

Insider Reports History

Location
Los Angeles, CA
Signature
/s/ John Kovach
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John S. Kovach:

Company Role Class Num Shares Value Price $ Report Date Ownership
LIXTE BIOTECHNOLOGY HOLDINGS, INC. President and CEO, Director Stock Options 200,000 06 Nov 2022 Direct
LIXTE BIOTECHNOLOGY HOLDINGS, INC. President and CEO, Director Warrants to Purchase Common Stock 21,100 06 Nov 2022 By John S. Kovach Trust

Insider Reports Filed by John S. Kovach

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. 06 Nov 2022 1 $0 4 President and CEO, Director 09 Nov 2022, 15:55